Jpmorgan Chase & CO Deciphera Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$13.58 - $17.36 $362,518 - $463,425	-26,695 Reduced 30.63%	60,453 $950,000
Q4 2023 Feb 12, 2024	BUY	$10.11 - $16.54 $44,959 - $73,553	4,447 Added 5.38%	87,148 $1.41 Million
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $29,243 - $36,331	2,347 Added 2.92%	82,701 $1.05 Million
Q2 2023 Aug 11, 2023	BUY	$13.28 - $15.96 $158,151 - $190,067	11,909 Added 17.4%	80,354 $1.13 Million
Q1 2023 May 18, 2023	BUY	$14.26 - $22.1 $951,641 - $1.47 Million	66,735 Added 3902.63%	68,445 $1.06 Million
Q1 2023 May 11, 2023	SELL	$14.26 - $22.1 $1.03 Million - $1.6 Million	-72,302 Reduced 97.69%	1,710 $26,000
Q4 2022 Feb 13, 2023	SELL	$14.85 - $19.04 $79,551 - $101,997	-5,357 Reduced 6.75%	74,012 $1.21 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $459,570 - $750,978	37,122 Added 87.87%	79,369 $1.47 Million
Q2 2022 Aug 11, 2022	SELL	$9.11 - $13.98 $2.93 Million - $4.49 Million	-321,234 Reduced 88.38%	42,247 $556,000
Q1 2022 May 11, 2022	BUY	$6.87 - $11.11 $1.65 Million - $2.66 Million	239,535 Added 193.26%	363,481 $3.37 Million
Q4 2021 Feb 10, 2022	BUY	$7.7 - $37.13 $748,825 - $3.61 Million	97,250 Added 364.29%	123,946 $1.21 Million
Q3 2021 Nov 12, 2021	BUY	$26.46 - $37.15 $706,376 - $991,756	26,696 New	26,696 $907,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.